These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 1634904)
21. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy. Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658 [TBL] [Abstract][Full Text] [Related]
22. The beta-oxidation of arachidonic acid and the synthesis of docosahexaenoic acid are selectively and consistently altered in skin fibroblasts from three Zellweger patients versus X-adrenoleukodystrophy, Alzheimer and control subjects. Petroni A; Bertagnolio B; La Spada P; Blasevich M; Papini N; Govoni S; Rimoldi M; Galli C Neurosci Lett; 1998 Jul; 250(3):145-8. PubMed ID: 9708853 [TBL] [Abstract][Full Text] [Related]
23. Protease inhibitors suppress the degradation of mutant adrenoleukodystrophy proteins but do not correct impairment of very long chain fatty acid metabolism in adrenoleukodystrophy fibroblasts. Yamada T; Shinnoh N; Kobayashi T Neurochem Res; 1997 Mar; 22(3):233-7. PubMed ID: 9051655 [TBL] [Abstract][Full Text] [Related]
24. Very long-chain fatty acids in neutral lipids and glycerophospholipids of adrenoleukodystrophy-cultured skin fibroblasts. Sakai T; Antoku Y; Goto I; Ochiai J; Iwashita H; Kuroiwa Y; Katafuchi Y J Neurol Sci; 1985 Dec; 71(2-3):301-6. PubMed ID: 4087027 [TBL] [Abstract][Full Text] [Related]
25. Lipid-induced endoplasmic reticulum stress in X-linked adrenoleukodystrophy. van de Beek MC; Ofman R; Dijkstra I; Wijburg F; Engelen M; Wanders R; Kemp S Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2255-2265. PubMed ID: 28666219 [TBL] [Abstract][Full Text] [Related]
27. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation. Inoue K; Suzuki Y; Yajima S; Shimozawa N; Tomatsu S; Orii T; Kondo N Clin Genet; 1996 Nov; 50(5):348-52. PubMed ID: 9007322 [TBL] [Abstract][Full Text] [Related]
28. Lipid and fatty acid composition of brain tissue from adrenoleukodystrophy patients. Wilson R; Sargent JR J Neurochem; 1993 Jul; 61(1):290-7. PubMed ID: 8515276 [TBL] [Abstract][Full Text] [Related]
29. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN). Tsuji S; Sano T; Ariga T; Miyatake T J Biochem; 1981 Oct; 90(4):1233-6. PubMed ID: 7309718 [TBL] [Abstract][Full Text] [Related]
30. Detection of adrenoleukodystrophy by increased C26:0 fatty acid levels in leukocytes. Molzer B; Bernheimer H; Heller R; Toifl K; Vetterlein M Clin Chim Acta; 1982 Nov; 125(3):299-305. PubMed ID: 7172439 [TBL] [Abstract][Full Text] [Related]
31. [Very long chain fatty acids in the pathogenesis, prenatal and postnatal diagnosis of X-linked adrenoleukodystrophy]. Grković S; Dordević M; Nikolić R; Zivancević-Simonović S; Puzigaća Z Med Pregl; 2007; 60(7-8):401-3. PubMed ID: 17990810 [TBL] [Abstract][Full Text] [Related]
32. Adrenoleukodystrophy: impaired oxidation of fatty acids due to peroxisomal lignoceroyl-CoA ligase deficiency. Lazo O; Contreras M; Bhushan A; Stanley W; Singh I Arch Biochem Biophys; 1989 May; 270(2):722-8. PubMed ID: 2705786 [TBL] [Abstract][Full Text] [Related]
33. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata. Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949 [TBL] [Abstract][Full Text] [Related]
34. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids. Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501 [TBL] [Abstract][Full Text] [Related]
35. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry. Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346 [TBL] [Abstract][Full Text] [Related]
36. Accumulation of very long-chain fatty acids does not affect mitochondrial function in adrenoleukodystrophy protein deficiency. Oezen I; Rossmanith W; Forss-Petter S; Kemp S; Voigtländer T; Moser-Thier K; Wanders RJ; Bittner RE; Berger J Hum Mol Genet; 2005 May; 14(9):1127-37. PubMed ID: 15772093 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy. McGuinness MC; Zhang HP; Smith KD Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822 [TBL] [Abstract][Full Text] [Related]
38. Simvastatin does not normalize very long chain fatty acids in adrenoleukodystrophy mice. Cartier N; Guidoux S; Rocchiccioli F; Aubourg P FEBS Lett; 2000 Aug; 478(3):205-8. PubMed ID: 10930569 [TBL] [Abstract][Full Text] [Related]
39. The Zellweger syndrome: deficient conversion of docosahexaenoic acid (22:6(n-3)) to eicosapentaenoic acid (20:5(n-3)) and normal delta 4-desaturase activity in cultured skin fibroblasts. Grønn M; Christensen E; Hagve TA; Christophersen BO Biochim Biophys Acta; 1990 May; 1044(2):249-54. PubMed ID: 2140517 [TBL] [Abstract][Full Text] [Related]
40. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders. Wanders RJ; van Roermund CW; van Wijland MJ; Heikoop J; Schutgens RB; Schram AW; Tager JM; van den Bosch H; Poll-Thé BT; Saudubray JM Clin Chim Acta; 1987 Jul; 166(2-3):255-63. PubMed ID: 2441904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]